Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AGEN Agenus > Detailed Quotes

AGEN Agenus

Watchlist
2.470
-0.090-3.52%
Close  12/07 16:00 ET
2.440
-0.030-1.21%
Post Mkt Price 12/07 19:27 ET
High
2.550
Open
2.540
Turnover
11.34M
Low
2.435
Pre Close
2.560
Volume
4.58M
Market Cap
752.88M
P/E(TTM)
Loss
52wk High
3.620
Shares
304.81M
P/E(Static)
Loss
52wk Low
1.250
Float Cap
628.79M
Bid/Ask %
40.00%
Historical High
429.000
Shs Float
254.57M
Volume Ratio
1.19
Historical Low
1.140
Dividend TTM
--
Div Yield TTM
--
P/B
-36.87
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.80%
Amplitude
4.49%
Avg Price
2.475
Lot Size
1
Float Cap
628.79M
Bid/Ask %
40.00%
Historical High
429.000
Shs Float
254.57M
Volume Ratio
1.19
Historical Low
1.140
Dividend TTM
--
P/B
-36.87
Dividend LFY
--
Turnover Ratio
1.80%
Amplitude
4.49%
Avg Price
2.475
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 31, 1994 and is headquartered in Lexington, MA.
CEO: Dr. Garo H. Armen, Pd.D
Market: NASDAQ
Listing Date: 02/04/2000
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist